Cargando…

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient

Patients with previous sensitization events against anti-human leukocyte antigens (HLA) often have circulating anti-HLA antibodies. Following organ transplantation, sensitized patients have higher rates of antibody-mediated rejection (AMR) compared to those who are non-sensitized. More stringent don...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olaso, Danae, Manook, Miriam, Moris, Dimitrios, Knechtle, Stuart, Kwun, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396983/ https://www.ncbi.nlm.nih.gov/pubmed/34441950 http://dx.doi.org/10.3390/jcm10163656

Ejemplares similares

Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
por: Manook, Miriam, et al.
Publicado: (2023)

Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
por: Choi, Ashley Y., et al.
Publicado: (2021)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Contemporary Strategies and Barriers to Transplantation Tolerance
por: Ezekian, Brian, et al.
Publicado: (2018)

A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines
por: Song, Shengli, et al.
Publicado: (2021)

Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells
por: Song, Shengli, et al.
Publicado: (2021)

Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients
por: Kwiatkowska, Marlena, et al.
Publicado: (2021)

Kidney transplantation in highly sensitized recipients
por: Park, Yohan, et al.
Publicado: (2021)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

COVID-19 Among Liver Transplant Recipients
por: Moris, Dimitrios
Publicado: (2021)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022)

Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients
por: Filipov, Jean Jeanov, et al.
Publicado: (2015)

A Historical Cohort in Kidney Transplantation: 55-Year Follow-Up of 72 HLA-Identical, Donor-Recipient Pairs
por: Shaw, Brian I., et al.
Publicado: (2021)

The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature
por: Angelico, Roberta, et al.
Publicado: (2021)

188 COVID-19 and Kidney Transplant Recipients: Immunosuppression Management and Outcomes
Publicado: (2021)

Follow-Up Factors Contribute to Immunosuppressant Adherence in Kidney Transplant Recipients
por: Chen, Tingting, et al.
Publicado: (2022)

Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: Schroder, Paul M., et al.
Publicado: (2017)

Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
por: Toapanta, Néstor, et al.
Publicado: (2022)

Complement-targeted therapies in kidney transplantation—insights from preclinical studies
por: Anwar, Imran J., et al.
Publicado: (2022)

Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
por: Ahlenstiel-Grunow, Thurid, et al.
Publicado: (2021)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Transplant of kidneys with small renal cell carcinoma in incompatible, heavily immunosuppressed recipients
por: Ali, AM, et al.
Publicado: (2012)

Factors Associated With Adherence To Immunosuppressive Therapy And Barriers In Asian Kidney Transplant Recipients
por: Ganjali, Raheleh, et al.
Publicado: (2019)

Prevalence of Non-Adherence to Immunosuppressive Medications in Kidney Transplant Recipients: Barriers and Predictors
por: Taj, Shahd M., et al.
Publicado: (2021)

Immunosuppressant Adherence Factors Differentiating Compliant and Non-Compliant Kidney Transplant Recipients
por: Ostrowski, Piotr, et al.
Publicado: (2023)

A case of varicella zoster infection in kidney transplant recipient using immunosuppressant
por: Adam, Abdirahim Ali Nur, et al.
Publicado: (2023)

Beyond Human Limits: Harnessing Artificial Intelligence to Optimize Immunosuppression in Kidney Transplantation
por: Basuli, Debargha, et al.
Publicado: (2023)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients
por: Zwart, Tom C., et al.
Publicado: (2022)

Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model
por: Manook, Miriam, et al.
Publicado: (2021)

Frailty in kidney transplant candidates and recipients: pathogenesis and intervention strategies
por: Cao, Huawei, et al.
Publicado: (2023)

Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies
por: Tang, Yangming, et al.
Publicado: (2023)

Hypertension in kidney transplant recipients
por: Alexandrou, Maria-Eleni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vij54en8cq0r2c47m377s5dppm